New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.
New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.
复制标题
DOI:
10.1002/jha2.70
复制
发表时间:
2020-11
期刊:
影响因子:
--
通讯作者:
Engelhardt BG
中科院分区:
文献类型:
--
作者:
Mangan BL;Patel D;Chen H;Gatwood KS;Byrne MT;Sengsayadeth S;Goodman S;Dholaria B;Kassim AA;Jagasia M;Chinratanalab W;Culos KA;Engelhardt BG
Haploidentical hematopoietic cell transplantation (haplo‐HCT) with posttransplant cyclophosphamide (PTCY) is utilized for patients with hematological disorders but without conventional donors. The effects of new‐onset posttransplant diabetes mellitus (PTDM) following haplo‐HCT are unknown. We examined PTDM incidence and outcomes after haplo‐HCT with PTCY. Patients without diabetes receiving haplo‐HCT (n = 64) were analyzed for PTDM diagnosis (defined as blood glucose ≥ 200 mg/dL). By day 100, 14 (22%) patients developed PTDM (median, 18 days). Hyperglycemia (blood glucose ≥ 200 mg/dL) preceded corticosteroids in 11 (79%) individuals. PTDM patients had increased death/relapse (P = .029). PTDM occurs frequently, precedes corticosteroids, and leads to inferior outcomes following haplo‐HCT. PTDM prophylaxis/treatment may improve HCT survival.
登录
查看更多内容
影响因子:
4.3
作者:
Hammer, Marilyn J.;Casper, Corey;Hirsch, Irl B.
通讯作者:
Hirsch, Irl B.
影响因子:
20.3
作者:
Armand, Philippe;Kim, Haesook T.;Saber, Wael
通讯作者:
Saber, Wael
影响因子:
4.3
作者:
Engelhardt, Brian G.;Savani, Ujjawal;Abumrad, Naji N.
通讯作者:
Abumrad, Naji N.
影响因子:
4.3
作者:
Majhail, Navneet S.;Challa, Tejo R.;Burns, Linda J.
通讯作者:
Burns, Linda J.
影响因子:
20.3
作者:
Baker, K. Scott;Ness, Kirsten K.;Bhatia, Smita
通讯作者:
Bhatia, Smita